Stockreport

How Much Upside is Left in Viridian Therapeutics, Inc. (VRDN)? Wall Street Analysts Think 97.81% [Yahoo! Finance]

Viridian Therapeutics, Inc.  (VRDN) 
PDF still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.79 [Read more]